Literature DB >> 16630639

Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis.

Nicolas Gauliard1, Agnès Billecocq, Ramon Flick, Michèle Bouloy.   

Abstract

Rift Valley fever virus (RVFV) (Phlebovirus, Bunyaviridae) possesses a genome composed of three negative-stranded RNA molecules. Each segment contains 3' and 5' noncoding regions with terminal complementary sequences forming a panhandle structure. We showed that transcription-replication of the L, M and S segments is regulated, and we established a minigenome rescue system expressing a CAT reporter to investigate the role of the noncoding regions in this process. The L, M and S segment-based minigenomes were shown to drive bona fide transcription and replication and to express variable levels of CAT reporter, indicating differential promoter activities within the noncoding sequences. In addition, we found a good correlation between the relative promoter strength and the abundance of viral RNA species in RVFV-infected cells. Altogether, these results show that RVFV minigenomes are powerful tools to study transcription and replication and constitute a valuable basis to rescue infectious virus from cDNAs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630639     DOI: 10.1016/j.virol.2006.03.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  38 in total

1.  Mechanism of tripartite RNA genome packaging in Rift Valley fever virus.

Authors:  Kaori Terasaki; Shin Murakami; Kumari G Lokugamage; Shinji Makino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Roles of the coding and noncoding regions of rift valley Fever virus RNA genome segments in viral RNA packaging.

Authors:  Shin Murakami; Kaori Terasaki; Krishna Narayanan; Shinji Makino
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.

Authors:  Alexander Freiberg; Lhia Krista Dolores; Sven Enterlein; Ramon Flick
Journal:  Virology       Date:  2007-09-27       Impact factor: 3.616

4.  Discovery and evolution of bunyavirids in arctic phantom midges and ancient bunyavirid-like sequences in insect genomes.

Authors:  Matthew J Ballinger; Jeremy A Bruenn; John Hay; Donna Czechowski; Derek J Taylor
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

5.  Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages.

Authors:  Xavier Carnec; Sylvain Baize; Stéphanie Reynard; Laure Diancourt; Valérie Caro; Noel Tordo; Michèle Bouloy
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 6.  Molecular aspects of Rift Valley fever virus and the emergence of reassortants.

Authors:  Natasha N Gaudreault; Sabarish V Indran; Velmurugan Balaraman; William C Wilson; Juergen A Richt
Journal:  Virus Genes       Date:  2018-11-13       Impact factor: 2.332

7.  Characterization of wild-type and alternate transcription termination signals in the Rift Valley fever virus genome.

Authors:  Estelle Lara; Agnès Billecocq; Psylvia Leger; Michèle Bouloy
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

8.  Molecular biology of rift valley Fever virus.

Authors:  Michele Bouloy; Friedemann Weber
Journal:  Open Virol J       Date:  2010-04-22

9.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

10.  RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses.

Authors:  Agnès Billecocq; Nicolas Gauliard; Nicolas Le May; Richard M Elliott; Ramon Flick; Michèle Bouloy
Journal:  Virology       Date:  2008-07-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.